First in the UAE

Cleveland Clinic Abu Dhabi Introduces Cardiac Neuroablation, an Advanced Procedure That Treats the Root Cause of Recurrent Fainting—Without a Permanent Device

• Minimally invasive procedure targets abnormal nerve signals affecting heart rhythm
• Offers an alternative to permanent pacemaker implantation in selected patients
• Marks a shift in cardiac care from symptom management to root-cause treatment

Abu Dhabi, United Arab Emirates. 14th May, 2026: In a step that reflects the evolution of cardiac care from managing symptoms to treating underlying causes, Cleveland Clinic Abu Dhabi has successfully performed the first cardiac neuroablation procedure in the United Arab Emirates. The minimally invasive intervention offers a new treatment pathway for patients suffering from recurrent fainting episodes, without the need for permanent pacemaker implantation in many cases.

• Cleveland Clinic Abu Dhabi introduces innovative Artisse Intrasaccular Flow Modulator for stroke treatment.
• As designated Center of Excellence for stroke, the hospital continues to expand access to safer, minimally invasive treatments for complex neurovascular conditions.
• The hospital’s multidisciplinary team of neurological experts delivers highly specialized care using advanced imaging and catheter-based precision to reduce surgical risks and improve long-term outcomes.

Abu Dhabi, August 19, 2025: Cleveland Clinic Abu Dhabi has set a new standard in the treatment of brain aneurysms in the Middle East and North Africa (MENA) region, adopting the first Artisse Intrasaccular Flow Modulator, a novel medical implant for wide-necked intracranial aneurysms. Designated by the Department of Health – Abu Dhabi as a Centre of Excellence (CoE), this milestone underscores the hospital’s position for stroke as it continues to advance medical technology and deliver world-class care for patients.

Abu Dhabi, 18 March 2025: His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, has attended the 10^th anniversary celebration of Cleveland Clinic Abu Dhabi, part of the M42 group, at Emirates Palace Mandarin Oriental in Abu Dhabi.

The event was attended by a number of senior officials and a distinguished group of global healthcare leaders. During the event, Cleveland Clinic Abu Dhabi’s journey and achievements were highlighted, along with its role in advancing the UAE’s healthcare sector.